NNNN (Anbio Biotechnology) FCF Margin %: 0.00% (As of Dec. 2025)


NNNN Anbio Biotechnology NNNN
24 GF Score
Price $12.46
! 2 Warning Signs
View Full Analysis

What is Anbio Biotechnology FCF Margin %?

Anbio Biotechnology NNNN +2.88% 24 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates NNNN with a GF Score™ of 24/100. The stock has 2 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Anbio Biotechnology ranks better than 87.16% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Anbio Biotechnology's Free Cash Flow for the six months ended in Dec. 2025 was $0.00 Mil. Anbio Biotechnology's Revenue for the six months ended in Dec. 2025 was $4.06 Mil. Therefore, Anbio Biotechnology's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Anbio Biotechnology's current FCF Yield % is 0.27%.

The historical rank and industry rank for Anbio Biotechnology's FCF Margin % or its related term are showing as below:

NNNN' s FCF Margin % Range Over the Past 10 Years
Min: -77.93   Med: 18.9   Max: 94.42
Current: 17.13

During the past 5 years, the highest FCF Margin % of Anbio Biotechnology was 94.42%. The lowest was -77.93%. And the median was 18.90%.

NNNN's FCF Margin % is ranked better than
87.16% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: -0.375 vs NNNN: 17.13

Anbio Biotechnology FCF Margin % Related Terms

Anbio Biotechnology FCF Margin % Historical Data

* Premium members only.

The historical data trend for Anbio Biotechnology's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anbio Biotechnology FCF Margin % Chart

Anbio Biotechnology Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
94.42 18.90 13.38 25.41 -77.93

Anbio Biotechnology Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only -33.76 10.24 63.40 0.00 0.00

NNNN vs ANGO, OSUR, UTMD: FCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, Anbio Biotechnology's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anbio Biotechnology FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anbio Biotechnology's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Anbio Biotechnology's FCF Margin % falls into.


NNNN
24GF Score
Anbio Biotechnology NNNN
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anbio Biotechnology FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Anbio Biotechnology's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-6.739/8.647
=-77.93 %

Anbio Biotechnology's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/4.062
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Anbio Biotechnology (NNNN) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Anbio Biotechnology and its competitors. According to the industry distribution chart, Anbio Biotechnology ranks #105 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 12.8%.
Is Anbio Biotechnology's FCF Margin % too high?
Anbio Biotechnology's current FCF Margin % is 0.00%. Based on the distribution chart, Anbio Biotechnology ranks #105 out of 818 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Anbio Biotechnology has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Anbio Biotechnology's FCF Margin % compare to ANGO and OSUR?
According to the Medical Devices & Instruments industry distribution chart, Anbio Biotechnology ranks #105 out of 818 companies for FCF Margin %. This places Anbio Biotechnology in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Anbio Biotechnology and its competitors. Anbio Biotechnology's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anbio Biotechnology stock overvalued right now?
Anbio Biotechnology (NNNN) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Anbio Biotechnology's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Anbio Biotechnology (NNNN), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anbio Biotechnology Business Description

Address Friedrich-Ebert-Anlage 35-37, Frankfurt am Main, HE, DEU, 60327
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
24GF Score

Get the complete analysis for NNNN

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.46
Price